Document Detail

The Efficacy and Tolerability of Commonly Used Agents to Prevent Recurrence of Atrial Fibrillation After Successful Cardioversion.
MedLine Citation:
PMID:  24604773     Owner:  NLM     Status:  Publisher    
A number of therapeutic strategies exist for the restoration and maintenance of sinus rhythm in patients presenting with atrial fibrillation. The acute success rate with electrical cardioversion is high. However, many patients relapse into atrial fibrillation. A major challenge faced by those who care for patients with atrial fibrillation is the long-term maintenance of sinus rhythm whilst avoiding treatment-related adverse effects. This review examines the efficacy and tolerability of conventional anti-arrhythmic drugs for the secondary prevention of atrial fibrillation in the post-cardioversion period.
Hanney Gonna; Mark M Gallagher
Related Documents :
10520773 - Treatment of atrial fibrillation in open heart surgery--the potential role of microwave...
7513883 - Catheter ablation of ventricular tachycardia occurring late after myocardial infarction...
18315993 - Outcomes of patients with stable heart failure undergoing elective noncardiac surgery.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-3-7
Journal Detail:
Title:  American journal of cardiovascular drugs : drugs, devices, and other interventions     Volume:  -     ISSN:  1179-187X     ISO Abbreviation:  Am J Cardiovasc Drugs     Publication Date:  2014 Mar 
Date Detail:
Created Date:  2014-3-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100967755     Medline TA:  Am J Cardiovasc Drugs     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evaluation of a starch-based double layer scaffold for bone regeneration in a rat model.
Next Document:  The Effect of Nutritional Supplements on Serum High-Density Lipoprotein Cholesterol and Apolipoprote...